⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ILMN News
Illumina Inc
Mass Notification System Market worth $80.44 billion by 2030 | MarketsandMarkets™
prnewswire.com
HON
MSI
BB
JCI
AMRN
ILMN
DIAL
Smart Precision Medicine Software Research Report 2025: Market Trends, Competitive Landscape, Strategies, and Opportunities, 2019-2024, 2024-2029F, 2034F
globenewswire.com
ORCL
IQV
ILMN
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More
globenewswire.com
ILMN
ONTF
PACB
Predictive Clinical Biomarkers Market worth $14.69 billion by 2030 | MarketsandMarkets™
prnewswire.com
TMO
BIO
ABT
PACB
ILMN
Genomic Testing Market Projected to Reach US$ 41.34 Billion by 2035, Supported by Rising Clinical Oncology Testing Volumes | Astute Analytica
globenewswire.com
NTRA
GH
EXAS
ILMN
PACB
TXG
TMO
TWST
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
prnewswire.com
ILMN
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
prnewswire.com
ILMN
Alamar Biosciences uzatvára nadupísané financovanie formou konvertibilných dlhopisov a rozširuje vedenie spoločnosti USA - slovenčina USA - English APAC - English USA - English USA - Français USA - Deutsch USA - Polski Korea - 한국어 USA - čeština USA -
prnewswire.com
ILMN
VERA
PFE
Компания Alamar Biosciences объявляет о закрытии финансирования за счет конвертируемых облигаций с превышением лимита подписки и о расширении руководящей команды USA - Pусский Korea - 한국어 USA - English APAC - English USA - English USA - Français USA -
prnewswire.com
ILMN
VERA
OM
MYGN
RVT
CSGP
BIIB
AMGN
PFE
TROW
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
globenewswire.com
ILMN
BMY